SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

344.5797109

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

52.08

9552.32

EPS(TTM)

Face Value()

Div & Yield %

19.9

0.39

Date	Headline
05-Feb-2026	Strides Pharma receives USFDA inspection closure report for its Chestnut Ridge facility
30-Jan-2026	Strides Pharma Science consolidated net profit rises 129.80% in the December 2025 quarter
30-Jan-2026	Strides Pharma Science jumps after strong Q3 performance
24-Jan-2026	Strides Pharma Science to conduct board meeting
26-Dec-2025	Strides Pharma slides as US arm receives 4 USFDA observations for New York facility
03-Dec-2025	Strides Pharma Science announces change in senior management
03-Dec-2025	Strides Pharma Science announces resignation of Group CHRO
03-Nov-2025	Sterling & Wilson Renewable Energy Ltd leads gainers in 'A' group
31-Oct-2025	Strides Pharma Science consolidated net profit rises 77.52% in the September 2025 quarter
31-Oct-2025	Strides Pharma soars after Q2 PAT climbs 82% YoY to Rs 131 cr

<< < 1 2 > >>

76,913.50 -582.86 ( -0.75%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)